All In Biotech

Drug Trial Radar · NCT04770610

Study of OT-101 in Treating Myopia

A Phase III, Randomized, Double-masked, Placebo-controlled, Parallel-group, Multicenter Study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects

Last checked: Nov 20, 2026Latest source record: Aug 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 678 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

678

Planned (sponsor's estimate)

Start

Apr 1, 2021

Primary completion

Mar 2027

Study completion Apr 2027

Sponsor

Lead sponsor
Ocumension (Hong Kong) LimitedAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
ORA, Inc.; Statistics & Data Corporation
First posted
Feb 25, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine sulfate 0.01% (OT-101) as an investigational treatment for myopia in pediatric subjects

Conditions

  • Myopia, Progressive

Interventions

  • OT-101 Ophthalmic SolutionDrug

    Atropine 0.01%

  • VehicleDrug

    Investigational Product minus active ingredient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of study eyes with a -0.75D of progressive myopia defined as an increase in spherical equivalent of -0.75D or greater as assessed by cycloplegic autorefraction.Time frame: At month 36

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Colorado Vision Institute

    Colorado Springs, Colorado

  • Eye Center of Northern Colorado, PC

    Fort Collins, Colorado

  • Family Focus

    Gainesville, Florida

  • Pediatric Eye Consultants of North Florida

    Jacksonville, Florida

  • Indiana University Health Physicians Pediatric Ophthalmology

    Indianapolis, Indiana

  • Kids Eye Care of Maryland

    Rockville, Maryland

  • Comprehensive Eye Care, Ltd.

    Washington, Missouri

  • Pure Ophthalmic Research

    Mint Hill, North Carolina

  • CORE, Inc.

    Shelby, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Scott & Christie and Associates

    Cranberry Township, Pennsylvania

  • Pediatric Ophthalmology of Erie, Inc

    Erie, Pennsylvania

  • UPMC Children's Hospital

    Pittsburgh, Pennsylvania

  • Total Eye Care, P.A.

    Memphis, Tennessee

  • San Antonio Eye Center

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.